Stocks and Investing
Stocks and Investing
Fri, February 26, 2021
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
Thu, February 25, 2021
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
[ Thu, Feb 25th 2021
] - WOPRAI
James Molloy Maintained (TNXP) at Strong Buy with Increased Target to $128 on, Feb 25th, 2021
James Molloy of Alliance Global Partners, Maintained "Tonix Pharmaceuticals Holding Corp." (TNXP) at Strong Buy with Increased Target from $96 to $128 on, Feb 25th, 2021.
James, nor any peers, have made any analyst calls on TNXP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources